Evommune, Inc. (EVMN) Executive Compensation
Evommune, Inc. (EVMN) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EVMN
CIK: 2044725
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerJoseph Scheriff
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-09-30 | PRIMARY DOCUMENT | 0001620548-26-000009 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-10-01 | 8-K | 0001193125-26-409865 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | 8-K | 0001193125-26-399378 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001193125-26-391390 | View SEC Doc Filr Page |
| 424B3 | 2026-09-09 | — | 424B3 | 0001193125-26-385431 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-08 | 8-K | 0001193125-26-385430 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001757283-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000080255-26-000581 | View SEC Doc Filr Page |
| 424B3 | 2026-08-06 | — | 424B3 | 0001193125-26-338017 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-337984 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-337964 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-29 | 8-K | 0001193125-26-324972 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-16 | — | SCHEDULE 13G Filing | 0000919574-26-004453 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | PRIMARY DOCUMENT | 0001757072-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-07 | PRIMARY DOCUMENT | 0001290976-26-000004 | View SEC Doc Filr Page |
| 424B3 | 2026-06-29 | — | 424B3 | 0001193125-26-286924 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001193125-26-286918 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | PRIMARY DOCUMENT | 0002091053-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | PRIMARY DOCUMENT | 0002092017-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | PRIMARY DOCUMENT | 0001620548-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-06-22 | — | 144 Filing | 0001950047-26-006381 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-02 | PRIMARY DOCUMENT | 0001216994-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-02 | PRIMARY DOCUMENT | 0001290976-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-02 | PRIMARY DOCUMENT | 0001347383-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | PRIMARY DOCUMENT | 0002092017-26-000005 | View SEC Doc Filr Page |